Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.4103/ijmbs.ijmbs_5_21
Family history in patients with end-stage renal disease on hemodialysis in Tripoli, Libya
![](https://www.thieme-connect.de/media/10.1055-s-00053247/202101/lookinside/thumbnails/10-4103-ijmbs-ijmbs-5-21_313512-1.jpg)
Background: End-Stage Renal Disease (ESRD) is a global health problem due to increasing its burden worldwide. High-risk groups include family members of patients with ESRD. Objectives: To determine the prevalence of ESRD among dialysis patients' families. At Al-Shat kidney dialysis Center, Tripoli, Libya. So can conclude that the ESRD patient is an index case for a high- risk population. Methods: All patients' data were collected through direct interview with the patients for 15- 20 minutes and by reviewing patients' charts. Patients who decline consent to participate and those with mental or speech disability were excluded, and patients on peritoneal dialysis. The study carried at Al-Shat kidney dialysis centre, Tripoli, Libya. In January 2019. Results: 261 patients were interviewed, mean age 51.8 years (±15), nearly half (48.7%) of them, between 45 to 65 years and 31.8% younger than 45 years. 56.3% were men, and 43.7% were women. The leading causes of ESRD in these patients were DM, HTN, congenital abnormalities (APCKD/VUR) and GN (35.2%, 22.2%, 10%, 8%). Positive family history of ESRD was reportedby 26.8% of these patients. From them, 47% (33/70) were between 45 to 65 years ofage. 58.6% were male (41/70). 34.3% have diabetic, 20% have HTN, 13%have congenital abnormalities, and 7% GN. Conclusions: Positive familyhistory of ESRD was high in dialysis patients. These patients can be used as anindex case to identify high- risk population.
Key-words:
ESRD End-Stage Renal Disease - DM Diabetes Millets - HTN Hypertension - APCKD AdultPolycystic Kidney Disease. VUR Vasico-Ureteric Reflux.Financial support and sponsorship
Nil.
Publication History
Received: 10 January 2021
Accepted: 24 March 2021
Article published online:
14 July 2022
© 2021. The Libyan Authority of Scientific Research and Technologyand the Libyan Biotechnology Research Center. All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License,permitting copying and reproductionso long as the original work is given appropriate credit. Contents may not be used for commercial purposes, oradapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Goleg FA, Kong NCT, Sahathevan R. Dialysis-treated end-stage kidney disease in Libya: Epidemiology and risk factors. Int Urol Nephrol 2014;46:1581–7.
- 2 Ghonemy TA, Farag SE, Soliman SA, El-Okely A, El-Hendy Y. Epidemiology and risk factors of chronic kidney disease in the El-Sharkia Governorate, Egypt. Saudi J Kidney Dis Transplant 2016;27:111.
- 3 Kumar J, Butt G, Maqbool F. Screening for chronic kidney disease in Family Members of Dialysis patients. 2020;21:262–4.
- 4 Satko SG, Freedman BI. The importance of family history on the development of renal disease. Curr Opin Nephrol Hypertens 2004;13:337–41.
- 5 El Minshawy O. End-stage renal disease in the El-Minia Governorate, Upper Egypt: an epidemiological study. Saudi J Kidney Dis Transplant 2011;22:1048.
- 6 Alashek WA, McIntyre CW, Taal MW. Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya. BMC Nephrol 2012;13:1–7.
- 7 Shahbaz M. Data from a large hemodialysis center form an industrial city: Demographics, etiology and hepatitis status. Pakistan J Kidney Dis 2019;3:173–9.
- 8 Freedman BI, Volkova N V., Satko SG, Krisher J, Jurkovitz C, Soucie JM, et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 2005;25:529–35.
- 9 Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney Int Suppl 2005;67:2001–4.
- 10 Kong X, Liu L, Zuo L, Yuan P, Li Z, Li W, et al. Association between family members of dialysis patients and chronic kidney disease: a multicenter study in China. BMC Nephrol 2013;14:2–7.
- 11 Jurkovitz C, Franch H, Shoham D, Bellenger J, McClellan W. Family members of patients treated for ESRD have high rates of undetected kidney disease. Am J Kidney Dis 2002;40:1173–8.
- 12 Bethesda MD. US Renal Data System, USRDS Annual Data Report. Atlas Chronic Kidney Dis End-Stage Ren Dis United States Natl Institutes Heal Natl Inst Diabetes Dig Kidney Dis. 2011.
- 13 Schaeffner ES, Kurth T, de Jong PE, Glynn RJ, Buring JE, Gaziano JM. Alcohol consumption and the risk of renal dysfunction in apparently healthy men. Arch Intern Med 2005;165:1048–53.
- 14 Nakai S, Hanafusa N, Masakane I, Taniguchi M, Hamano T, Shoji T, et al. An Overview of Regular Dialysis Treatment in Japan (as of 31 D December 2012). Ther Apher Dial 2014;18:535–602.
- 15 Hsu C, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009;169:342–50.
- 16 Orth SR, Stöckmann A, Conradt C, Ritz E, Ferro in collaboration with M, Kreusser W, et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998;54:926–31.
- 17 Tuttle KR, Bakris GL, Bilous RW, Chiang JL, De Boer IH, Goldstein-Fuchs J, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis 2014;64:510–33.
- 18 Data S. Dialysis in the Kingdom of Saudi Arabia. Saudi J Kidney Dis Transpl 2015;26:839–48.
- 19 Akel M, Hamadeh G. Quality of diabetes care in a university health center in Lebanon. Int J Qual Heal Care 1999;11:517–21.
- 20 El-Reshaid K, Johny K V, Sugathan TN, Hakim A, Gorgeous M, Nampoory MRN. End-stage renal disease and renal replacement therapy in Kuwait-epidemiological profile over the past 4 1/2 years. Nephrol Dial Transplant 1994;9:532–538.
- 21 Al-Rohani M. Causes of chronic renal failure at one center in Yemen. Saudi J Kidney Dis Transplant 2003;14:80.
- 22 Saeed AA, Al-Hamdan NA, Bahnassy AA, Abdalla AM, Abbas MA, Abuzaid LZ. Prevalence, awareness, treatment, and control of hypertension among Saudi adult population: a national survey. Int J Hypertens 2011;2011.
- 23 El-Minshawy O, Kamel EG. Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study. Int Urol Nephrol 2011;43:507–12.
- 24 Suleymanlar G, Altiparmak MR, Seyahi N, Tribulus S. Registry of the Nephrology. Dial Transplant Turkey (Registry-2011) Turkish Soc Nephrol Istanbul, Turkey. 2012.
- 25 Nemati E, Ghanbarpour F, Taheri S, Einollahi B. Prevalence of hypertension among Iranian hemodialysis patients and associated risk factors: a nationwide multicenter study. Pak J Biol Sci 2008;11:910–4.
- 26 United States Renal Data System, 2012. Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases division of Kidney, urologic& hematologic dis. 2012.
- 27 El-Amin A, Obeid W A-AH. Renal replacement therapy in Sudan. Arab J Nephrol Transplant 2009;3:31–6.
- 28 Fituri OM, Shigidi MMT, Ramachandran G, Rashed AH. Demographic data and hemodialysis population dynamics in Qatar: A five year survey. Saudi J Kidney Dis Transplant 2009;20:493.
- 29 Shaheen FAM, Al-Khader AA. Epidemiology and causes of end-stage renal disease (ESRD). Saudi J Kidney Dis Transplant 2005;16:277.
- 30 Malekmakan L, Haghpanah S, Pakfetrat M, Malekmakan A, Khajehdehi P. Causes of chronic renal failure among Iranian hemodialysis patients. Saudi J Kidney Dis Transplant 2009;20:501.
- 31 Freedman BI, Soucie JM, Mcclellan WM. Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol 1997;8:1942–5.
- 32 Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. N Engl J Med 1989;320:1161–5.
- 33 Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990;33:438–43.
- 34 Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. Br Med J 1991;303:81–7.
- 35 Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456–62.